• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Organizational restructuring and new focus for growth





Heard company is going through complete managerial re-org. and effort to focus on new growth. Is anyone seeing a shift to a more sales-oriented culture?
Nope. The new managerial team fell on their face and still can't get up. JA and SZ were fired and NS is in hiding. A bunch of good reps found better jobs and now CBL does not have a salesforce. Unfortunately CBL can't find anyone to work for them. CBL is good at Pathology but terrible at business.